Manganese Chloride
CAS 7773-01-5
Manganese Chloride (CAS 7773-01-5) is a pharmaceutical compound with 0 bioactivity targets and 28 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Manganese Chloride | 29261 | SU | MTHSPL |
| MANGANESE CHLORIDE | 29261 | SU | MTHSPL |
| manganese chloride | 29261 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Manganese Chloride used for in pharmaceutical contexts?
Manganese Chloride (CAS 7773-01-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Manganese Chloride?
Manganese Chloride has 28 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Blood zinc increased, Bone marrow failure, Cardiac flutter, Copper deficiency, Cytopenia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Manganese Chloride also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Manganese Chloride with EU status "permitted".
What clinical phase is Manganese Chloride in?
No phase 1-4 clinical development badge is rendered for Manganese Chloride because the matched compound identifier rows do not contain a max-phase value.